Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

HR vs NHP: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

HR Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 8–2 Matrix Metrics)

HR Overall Winner 6-Pillar Tally: HR 5 – 1 NHP Matrix Metrics: HR 8 – 2 NHP

As of Nov 20, 2026, Healthcare Realty Trust Incorporated (HR) is the stronger overall head-to-head candidate over NHP (NHP) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HR carries a Unified Composite Score of 48.3/100 (HOLD) at $19.36 (10.8x Forward P/E, 13.2% operating margin), whereas NHP carries 54.6/100 (HOLD) at $14.82 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While NHP currently prints a higher short-term Unified Composite Score (54.6/100 HOLD vs. HR 48.3/100 HOLD), HR captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (13.2% vs. N/A operating margin) and revenue trajectory (-3.6% vs. N/A YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About HR vs NHP
HR NYSE Head-to-Head Winner
Healthcare Realty Trust Incorporated
Real Estate Investment Trusts
$19.36
+0.0% 1D
Market Cap $6.7B
TTM Revenue $1.14B
Forward P/E 10.8x
Beta / 30D Vol 0.08β · 21% Vol
Unified Composite Score
48.3 / 100 HOLD
Tech 33.0 Fund 44.0 Flow 48.0 Mom 56.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 64
RSI-14: 63.8 · SMA20: $18.96 · SMA50: $18.21
NHP US Equity
NHP
Institutional Equity
$14.82
+2.14% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.20β · 34% Vol
Unified Composite Score
54.6 / 100 HOLD
Tech 64.0 Fund 51.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 45
RSI-14: 45.1 · SMA20: $15.13 · SMA50: $15.48

6-Pillar Scorecard Institutional Category Breakdown (HR 5 – 1 NHP)

Columns: Metric · HR · NHP
1. Valuation Multiples HR
Forward P/E 10.8x N/M
Trailing P/E 10.8x N/M
PEG Ratio 8.82x N/M
EV / Revenue 9.8x N/M
2. Growth & Scale HR
Revenue Growth (YoY) -3.6% N/A
Earnings Growth (YoY) -76.8% N/A
TTM Revenue (USD) $1.14B N/A
Market Cap $6.7B N/A
3. Profitability & Quality HR
Gross Margin 61.9% N/A
Operating Margin 13.2% N/A
Net Profit Margin -4.0% N/A
Return on Equity (ROE) -1.0% N/A
4. Balance Sheet & Cash Flow HR
Cash Generation (TTM) $169M N/A
Cash Flow Margin 14.8% N/A
Net Cash / Leverage $4.47B Net Debt (1.10x D/E) N/A ROE
Dividend Yield 4.96% None (0.00%)
5. Options & Positioning NHP
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 28.0% (9th %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Neutral
6. R&D & Supply-Chain Moat HR
OpEx & R&D Intensity 48.7% of Rev ($554M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role REIT - Healthcare Facilities Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: HR (8) vs NHP (2)
Institutional Metric HR NHP Criterion Row Edge
Market Capitalization
Scale
$6.7B N/A Larger Scale HR
Trailing P/E Ratio
Valuation
10.8x N/M Lower Multiple HR
Forward P/E Ratio
Valuation
10.8x N/M Lower Multiple HR
Revenue Growth (YoY)
Growth
-3.6% N/A Higher Growth HR
Operating Margin (TTM)
Profitability
13.2% N/A Higher Margin HR
Net Profit Margin
Profitability
-4.0% N/A Higher Margin HR
Return on Equity (ROE)
Capital Efficiency
-1.0% N/A Higher ROE HR
52-Week Range Position
Momentum
53% ($16–$22) 58% ($11–$17) Stronger Trend NHP
Beta / 30D Volatility
Risk Regime
0.08β · 21% Vol 0.20β · 34% Vol Lower Realized Risk HR
Unified Institutional Score
Composite Signal
48.3 / 100 (HOLD) 54.6 / 100 (HOLD) Higher Composite NHP
Trailing 12M Revenue (USD)
Operating Scale
$1.14B N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
61.9% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
8.82x PEG · 9.8x EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$169M ($4.47B Net Debt (1.10x D/E)) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon HR +14.18 pp
HR: +7.98% · NHP: -6.2%
3M Horizon HR +10.99 pp
HR: +0.21% · NHP: -10.78%
6M Horizon NHP +5.52 pp
HR: -4.91% · NHP: +0.61%
1Y Horizon NHP +17.77 pp
HR: +5.73% · NHP: +23.5%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HR vs NHP. Trailing 12-month operating profitability (HR 13.2% vs NHP N/A) and valuation multiples (HR 10.8x vs NHP N/M Forward P/E) are benchmarked directly in Pillar 4 below.

HR ADR TTM Benchmark FX-Normalized USD
TTM Revenue$1.14B
Gross Margin61.9%
Op. Margin13.2%
ROE / Fwd P/E-1.0% · 10.8x
NHP ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
HR CONSOLIDATION
112d in phase · OBV NEUTRAL
Current IV 28.0%
IV Percentile 9th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact HR Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
NHP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact NHP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
HR Moat Profile Cyclical / Execution-Driven Positioning
REIT - Healthcare Facilities Operator
Competes within the REIT - Healthcare Facilities value chain with $6.7B market capitalization and 13.2% operating margin.
OpEx & R&D Reinvestment 48.7% of Rev ($554M)
90D Engineering Disclosures 0 Published
NHP Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ HR vs NHP Key Questions & Quantitative Answers

As of Nov 20, 2026, Healthcare Realty Trust Incorporated (HR) is the stronger overall head-to-head candidate over NHP (NHP) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HR carries a Unified Composite Score of 48.3/100 (HOLD) at $19.36 (10.8x Forward P/E, 13.2% operating margin), whereas NHP carries 54.6/100 (HOLD) at $14.82 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While NHP currently prints a higher short-term Unified Composite Score (54.6/100 HOLD vs. HR 48.3/100 HOLD), HR captures the overall institutional head-to-head verdict (8–2 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (13.2% vs. N/A operating margin) and revenue trajectory (-3.6% vs. N/A YoY).

HR leads the Growth & Scale pillar: HR posts -3.6% YoY revenue growth and -76.8% YoY earnings growth on $1.14B TTM revenue (61.9% gross margin, 13.2% operating margin), compared with NHP at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, HR generates $1.14B in USD-normalized revenue versus N/A for NHP. In operating R&D and SG&A reinvestment, HR deploys 48.7% of Rev ($554M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for NHP.

HR screens cheaper on headline valuation multiples. HR trades at 10.8x Forward P/E, 10.8x Trailing P/E, 8.82x PEG, and 9.8x EV/Revenue (14.8% FCF margin), whereas NHP trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HR (-1.0% ROE) versus NHP (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, HR carries 28.0% implied volatility (9th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.08β · 21% Vol realized risk). By comparison, NHP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.20β · 34% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.